These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31175529)

  • 1. The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis.
    Osman M; Kheiri B; Munir MB; Moreland JA; Balla S; Kapadia S
    J Thromb Thrombolysis; 2019 Oct; 48(3):516-518. PubMed ID: 31175529
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.
    Kheiri B; Osman M; Bakhit A; Radaideh Q; Abdalla A; Barbarawi M; Zayed Y; Ahmed S; Bachuwa G; Hassan M
    J Thromb Thrombolysis; 2019 Oct; 48(3):511-513. PubMed ID: 31054120
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapy.
    Collet JP; Thiele H
    Eur Heart J; 2021 May; 42(20):2020-2021. PubMed ID: 33186459
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 5. The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.
    Hall TS; Atar D
    Eur J Intern Med; 2021 Jun; 88():21-22. PubMed ID: 33934970
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.
    Siddiqi R; Yamani N; Alnaimat S; Khurshid A; Siddiqui S; Khan MS; Khan SU
    Eur J Prev Cardiol; 2020 Dec; 27(19):2119-2122. PubMed ID: 31349774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome].
    Tubaro M; Falaschi G; Colivicchi F
    G Ital Cardiol (Rome); 2018 Oct; 19(10):552-562. PubMed ID: 30281043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple antithrombotic therapy and dual therapy - What is the evidence base?
    Essa H; Sankaranarayanan R; Walker L
    Br J Clin Pharmacol; 2022 Jul; 88(7):3009-3012. PubMed ID: 35172379
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].
    Gallet R; Teiger E
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?
    Tseng AS; Shamoun FE; Marks LA; Agrwal N
    Cleve Clin J Med; 2021 Jul; 88(7):389-392. PubMed ID: 34210713
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple Antithrombotic Therapy - Always One Too Many?
    Fukaya H; Ako J
    Circ J; 2016; 80(2):316-7. PubMed ID: 26763466
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    Rodriguez F; Harrington RA
    N Engl J Med; 2021 Feb; 384(5):452-460. PubMed ID: 33534976
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola A; García-Dorado D
    Coron Artery Dis; 2015 Aug; 26(5):367-8. PubMed ID: 25955251
    [No Abstract]   [Full Text] [Related]  

  • 14. Things We Do for No Reason™: Routine use of triple anticoagulant therapy in patients with both nonvalvular atrial fibrillation and percutaneous coronary intervention.
    Garst C; Pitliya A; Iannetti M; Caccamo M
    J Hosp Med; 2022 Nov; 17(11):917-920. PubMed ID: 35527539
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy in hospitalized patients: facts and controversies.
    Srour JF; Smetana GW
    J Hosp Med; 2011 Nov; 6(9):537-45. PubMed ID: 21374797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract]   [Full Text] [Related]  

  • 18. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 19. New anticoagulants in combination with antiplatelet agents.
    Johansen H; Rutherford OW; Aamodt AH; Russell D; Atar D; Ghanima W
    Tidsskr Nor Laegeforen; 2016 Oct; 136(18):1543-1546. PubMed ID: 27731598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
    Capodanno D; Angiolillo DJ
    Circ Cardiovasc Interv; 2014 Feb; 7(1):113-24. PubMed ID: 24550531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.